A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, The Future of Memory Disorders, features profiles of Accera Inc., GBtherapeutics Ltd., Saegis Pharmaceuticals Inc. and Sention Inc. Plus these selected Start-Ups across Health Care: Anosys Inc., Ceretek LLC, Fossa Medical Inc. and Peoples Genetics Inc.

Less than two years after Fossa Medical Inc.'s formation, its lead product, the Stone Sweeper, has been 510(k) cleared for use as both an expanding ureteral stent and as a tool for kidney stone removal. It is the first device approach specifically targeting small kidney stones or fragments in the 3-to-5 mm range, and the first that will enable stone removal in an outpatient setting.

In Vivo briefly summarizes the technologies of these recently founded companies: Amphora Discovery Corp., Aptamera Inc., DxS Ltd., Fossa Industries Inc., Medgenics Inc. and Molecular SkinCare Ltd.